Duke researchers study an approach that may help millions manage diabetic neuropathy and chemotherapy-induced nerve pain.
Last year was a crucial year of learning for spine and orthopedic leaders, with artificial intelligence understanding and implementation being a top priority for many. Other changes surgeons are ...
John Peacock, 42, fell backwards off a 4-ft. ladder and sustained severe brain trauma while installing a lightbulb ...
The FDA approves the Allurion balloon for weight loss, which is swallowed and doesn't require a procedure for removal.
Zacks Small Cap Research on MSN
CYCN: Positive feedback from FDA sets stage for phase 2 trial of CYC-126 in 2H26
By David Bautz, PhD NASDAQ:CYCN READ THE FULL CYCN RESEARCH REPORT Business Update Positive Regulatory Feedback Supports Phase 2 Trial Initiation in 2H26 On February 17, 2026, Cyclerion Therapeutics, ...
Congratulations to the more than two dozen employees ( full list below) selected for the 2026 cohort of the Developing Emerging Administrative Leaders program, or DEAL, a transformative, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results